ML MEDIC
ActiveSummary
ML MEDIC has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36,131 and a net result of €15,646. Its solvency ranks better than 82% of 3,019 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
19-06
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Liquidity more than quadruplescurrent ratio 21.79
Current ratio from 4.85 to 21.79; short-term debt falls from €5,886 to €1,879.
16-06
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
16-12
Gazette deed
IncorporationAppointment: LEJEUNE Mathilde (director) · Permanent representative: LEJEUNE Mathilde · Founder9 facts ▸
Gazette deed
Incorporation
Appointment: LEJEUNE Mathilde (director) · Permanent representative: LEJEUNE Mathilde · Founder9 facts ▸
- Incorporation, “ML MEDIC” (deed in French)
- Founder, LEJEUNE Mathilde (comparant constituant)
- Founding capital, €3,000
- Other provision, “conformément à la loi, décisions suivantes effectives seulement à compter du dépôt au greffe d’une expédition de l’acte constitutif” (deed in French)
- Registered office clause, “5100 Namur (Wépion),Chaussée de Dinant,1112” (deed in French)
- Director appointment, LEJEUNE Mathilde (director (not named in the articles))
- Other provision, “administrateur, rémunération administrateur” (deed in French)
- Permanent representative, LEJEUNE Mathilde (représentant permanent de la société)
- Pre-incorporation commitments, “takeover, tous engagements et obligations et activités entreprises au nom et pour compte de la société en formation” (deed in French)
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 1 deed read